News

US-based GlobeImmune has initiated a Phase I clinical trial to investigate the safety and tolerability of a new Tarmogen, GI-6207, in patients with metastatic cancers that over-express carcinoembryonic

The FDA has given clearance to the ezlase for the following indications: for a temporary relief of minor muscle and joint pain and stiffness, minor arthritis pain, or

GlaxoSmithKline and Pfizer have entered into an agreement to create a new HIV company focused solely on research, development and commercialization of HIV medicines. GlaxoSmithKline (GSK) will initially

Somanetics, a developer of non-invasive patient monitoring systems, has received a new 510(k) clearance from the FDA to expand the labeling for its Invos cerebral/somatic oximeter. The new

Applied DNA Sciences, a provider of DNA security solutions, has opened an authentication laboratory in Huddersfield, Yorkshire, UK. The laboratory will produce forensic evidence of originality and product

Achillion Pharmaceuticals, a US-based biopharmaceutical company has announced that the US Patent & Trademark Office has granted Achillion a US patent related to the company’s NS4A antagonists to

Mednax, a provider of neonatal, maternal-fetal and pediatric physician services, has implemented Courion’s Enterprise Suite to assure access to critical systems and data for its approximately 5,000 clinical

The department’s online resource titled: “Genetic Evaluation and Testing for Hereditary Colorectal Cancer: What You Should Know.” The resource provides answers to many questions such as: How often

Complete first quarter 2009 unaudited interim financial results are anticipated to be released on May 15, 2009. “Our exceptional performance this quarter shows that our strategy is working,”